Kimia Therapeutics
CA - BerkeleyBiotechnology
Focus: Kimia Therapeutics is a Berkeley-based biotechnology company focused on metabolic disease treatments with a diversified pipeline spanning stem cell therapies, vaccines, and dermatology indications. The company operates at a pre-revenue or early-stage biotech scale with limited public disclosure of employee count or funding details.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Kimia Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Kimia Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Kimia Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SARS-CoV-2 vaccine
COVID-19Clinical Trials (1)
NCT05126550The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine
N/AHelp build intelligence for Kimia Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.